Menopause triggers a dramatic reshuffling of your body’s hormonal landscape. Estradiol, the most potent form of estrogen, drops from a premenopausal range of roughly 30 to 350 pg/mL down to less than 10 pg/mL after menopause. But estrogen isn’t the only hormone affected. Progesterone, testosterone, and several signaling hormones from the brain all shift in ways that ripple through nearly every system in your body.
What Happens Inside the Feedback Loop
Before menopause, your brain and ovaries run a tightly coordinated communication loop. The hypothalamus (a small region at the base of the brain) sends signals to the pituitary gland, which releases two key hormones: FSH (follicle-stimulating hormone) and LH (luteinizing hormone). These travel through the bloodstream to the ovaries, prompting them to produce estrogen and progesterone. When estrogen levels rise high enough, the brain dials back its signals. This cycle repeats roughly every month.
During the menopausal transition, the ovaries gradually stop responding. They have fewer and fewer viable egg follicles, so they produce less estrogen and progesterone even when the brain keeps sending FSH and LH. The brain, sensing low estrogen, ramps up its signals in an attempt to get the ovaries working harder. The result is a characteristic pattern: estrogen and progesterone fall while FSH and LH climb. FSH levels above 30 IU/L are consistent with perimenopause, and postmenopausal women commonly have FSH levels in the 70 to 90 IU/L range.
The Estrogen Drop in Numbers
Estrogen isn’t a single hormone. The body produces several forms, and which one dominates changes after menopause.
Before menopause, estradiol (E2) is the primary estrogen. It fluctuates throughout the menstrual cycle, peaking before ovulation at roughly 150 to 350 pg/mL, with some women reaching even higher levels. After menopause, ovarian production of estradiol essentially stops. In women more than 10 years past their final period, the median estradiol level is just 4.1 pg/mL, a fraction of what it was during reproductive years.
Estrone (E1), a weaker form of estrogen, becomes the dominant type after menopause. Postmenopausal estrone levels typically range from 7 to 40 pg/mL, with a median around 22 pg/mL in women a decade or more past menopause. While estrone is far less potent than estradiol, it’s the main estrogen your body has to work with from this point forward.
Where Estrogen Comes From After Menopause
Your ovaries aren’t the only tissues capable of producing estrogen. After menopause, the body shifts to a decentralized system. The adrenal glands (small glands sitting on top of each kidney) produce a precursor hormone called DHEA, which various tissues then convert into estrone and small amounts of estradiol. Fat tissue is one of the most important conversion sites, and the enzyme responsible for this conversion actually becomes more active with age.
This means body composition directly influences postmenopausal estrogen levels. Women with more body fat generally produce more estrone. The estrogen made in these peripheral tissues acts mostly locally, within the tissue itself, rather than circulating widely through the bloodstream the way ovarian estrogen did. This is a fundamentally different hormonal arrangement than what existed before menopause.
Progesterone Drops First
Progesterone actually begins declining before estrogen does. The ovaries produce progesterone after ovulation each month, so as cycles become irregular and ovulation happens less frequently during perimenopause, progesterone levels fall. By the time menopause arrives, progesterone production is negligible.
This early decline matters because progesterone influences more than reproduction. It plays a role in mood regulation and sleep quality. Low progesterone can contribute to anxiety, depression, and difficulty sleeping. It also creates a temporary imbalance during perimenopause: estrogen may still be relatively high (or even spiking unpredictably) while progesterone is already low. This imbalance, sometimes called estrogen dominance, can intensify symptoms like heavy periods, breast tenderness, and mood swings during the years leading up to menopause.
What Happens to Testosterone
Women produce roughly three times as much testosterone as estrogen before menopause, a fact that surprises many people. Testosterone plays a role in energy, libido, muscle maintenance, and mood.
Unlike estrogen, testosterone doesn’t plummet at a specific point tied to menopause. Instead, it declines gradually with age, starting in the late 20s and 30s. By the time a woman reaches menopause, her testosterone levels are already significantly lower than they were a decade or two earlier. Women who have their ovaries surgically removed experience a more abrupt testosterone drop, since the ovaries continue contributing to testosterone production even after menopause.
The practical effect is that the ratio between estrogen and testosterone shifts. With estradiol falling sharply and testosterone declining more slowly, some women notice subtle androgenic effects after menopause, like changes in hair distribution. But overall testosterone levels are still lower than they were in younger years.
The Perimenopause Roller Coaster
The transition to menopause typically lasts four to eight years, and the hormonal changes during this window are anything but smooth. Rather than a steady decline, estrogen levels become erratic. Some months, the ovaries may release a large burst of estrogen; other months, very little. FSH levels fluctuate too, which is why a single blood test during perimenopause can be misleading. The FSH test is not considered diagnostic for menopause on its own, precisely because levels swing so widely during the transition.
This volatility is what makes perimenopause symptoms so unpredictable. Hot flashes, night sweats, mood changes, and irregular bleeding can come and go without a clear pattern, matching the hormonal turbulence underneath.
Predicting When Menopause Will Arrive
One hormone has emerged as a useful predictor of timing: anti-Müllerian hormone (AMH). AMH is produced by the remaining egg follicles in the ovaries, so its level reflects your ovarian reserve. In a large prospective study, women with AMH levels below 0.20 ng/mL reached menopause in a median of about 6 years, while those with levels above 1.50 ng/mL had a median of roughly 13 years before their final period. AMH proved to be a stronger predictor of time to menopause than either FSH or inhibin B.
Age still matters in interpreting AMH. A 46-year-old with very low AMH is likely closer to menopause than a 36-year-old with the same level. Once AMH becomes undetectable, the median time to the final period is about 6 years. While no test can pinpoint the exact date, AMH gives a more reliable window than other available markers.
Long-Term Hormonal Baseline
After menopause is fully established, hormone levels settle into a new, lower equilibrium. Estradiol stays below 10 pg/mL. Estrone hovers in the 7 to 40 pg/mL range. FSH remains elevated. Progesterone is essentially absent. This new baseline is permanent without hormone therapy.
These sustained low levels of estrogen have consequences beyond reproductive function. Estrogen receptors exist throughout the body, in bone, the cardiovascular system, the brain, the urinary tract, and the skin. The long-term withdrawal of estrogen is what drives the increased risks of osteoporosis, cardiovascular changes, vaginal and urinary tissue thinning, and shifts in cholesterol profiles that develop in the years following menopause. The hormonal shift isn’t just an event. It’s a new physiological state your body adapts to over the rest of your life.